• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GMCSF-武装痘苗病毒诱导抗肿瘤免疫应答。

GMCSF-armed vaccinia virus induces an antitumor immune response.

机构信息

Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland.

出版信息

Int J Cancer. 2015 Mar 1;136(5):1065-72. doi: 10.1002/ijc.29068. Epub 2014 Jul 10.

DOI:10.1002/ijc.29068
PMID:25042001
Abstract

Oncolytic Western Reserve strain vaccinia virus selective for epidermal growth factor receptor pathway mutations and tumor-associated hypermetabolism was armed with human granulocyte-macrophage colony-stimulating factor (GMCSF) and a tdTomato fluorophore. As the assessment of immunological responses to human transgenes is challenging in the most commonly used animal models, we used immunocompetent Syrian golden hamsters, known to be sensitive to human GMCSF and semipermissive to vaccinia virus. Efficacy was initially tested in vitro on various human and hamster cell lines and oncolytic potency of transgene-carrying viruses was similar to unarmed virus. The hGMCSF-encoding virus was able to completely eradicate subcutaneous pancreatic tumors in hamsters, and to fully protect the animals from subsequent rechallenge with the same tumor. Induction of specific antitumor immunity was also shown by ex vivo co-culture experiments with hamster splenocytes. In addition, histological examination revealed increased infiltration of neutrophils and macrophages in GMCSF-virus-treated tumors. These findings help clarify the mechanism of action of GMCSF-armed vaccinia viruses undergoing clinical trials.

摘要

携带人粒细胞-巨噬细胞集落刺激因子(GMCSF)和 tdTomato 荧光蛋白的表皮生长因子受体通路突变和肿瘤相关高代谢选择的溶瘤性西方储备株痘苗病毒被武装。由于在最常用的动物模型中评估对人源转基因的免疫反应具有挑战性,我们使用免疫活性的叙利亚金黄地鼠进行研究,已知其对人源 GMCSF 敏感且对半许可的痘苗病毒敏感。最初在各种人和仓鼠细胞系上进行了体外功效测试,携带转基因的病毒的溶瘤效力与无武装病毒相似。携带 hGMCSF 基因的病毒能够完全根除仓鼠皮下胰腺肿瘤,并完全保护动物免受相同肿瘤的后续再挑战。通过与仓鼠脾细胞的体外共培养实验也证明了诱导特异性抗肿瘤免疫。此外,组织学检查显示 GMCSF 病毒处理的肿瘤中中性粒细胞和巨噬细胞的浸润增加。这些发现有助于阐明正在进行临床试验的 GMCSF 武装痘苗病毒的作用机制。

相似文献

1
GMCSF-armed vaccinia virus induces an antitumor immune response.GMCSF-武装痘苗病毒诱导抗肿瘤免疫应答。
Int J Cancer. 2015 Mar 1;136(5):1065-72. doi: 10.1002/ijc.29068. Epub 2014 Jul 10.
2
Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.Tian Tan 株 GM-CSF 武装痘苗病毒的溶瘤和免疫肿瘤治疗。
Cancer Lett. 2016 Mar 28;372(2):251-7. doi: 10.1016/j.canlet.2016.01.025. Epub 2016 Jan 21.
3
A novel therapeutic regimen to eradicate established solid tumors with an effective induction of tumor-specific immunity.一种新的治疗方案,可有效诱导肿瘤特异性免疫,从而根除已建立的实体肿瘤。
Clin Cancer Res. 2012 Dec 15;18(24):6679-89. doi: 10.1158/1078-0432.CCR-12-0979. Epub 2012 Oct 22.
4
Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy.具有增强溶瘤潜力的双重组痘苗病毒用于实体瘤病毒疗法的工程构建
Oncotarget. 2016 Nov 8;7(45):74171-74188. doi: 10.18632/oncotarget.12367.
5
Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy.接受Ad5/3-E2F-Δ24-GMCSF治疗的癌症患者的免疫学数据表明其对肿瘤免疫治疗具有实用性。
Oncotarget. 2015 Feb 28;6(6):4467-81. doi: 10.18632/oncotarget.2901.
6
Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans.GM-CSF 编码的 5/3 嵌合溶瘤腺病毒治疗黑色素瘤:体外、啮齿动物和人体的结果。
Int J Cancer. 2015 Oct 1;137(7):1775-83. doi: 10.1002/ijc.29536. Epub 2015 Apr 11.
7
Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing.溶瘤痘苗病毒基因修饰及其细胞因子表达对肿瘤感染、免疫反应和杀伤的影响。
Mol Cancer Ther. 2021 Aug;20(8):1481-1494. doi: 10.1158/1535-7163.MCT-20-0863. Epub 2021 May 27.
8
A vaccinia virus armed with interleukin-10 is a promising therapeutic agent for treatment of murine pancreatic cancer.携带白细胞介素-10 的牛痘病毒是治疗小鼠胰腺癌的有前途的治疗剂。
Clin Cancer Res. 2015 Jan 15;21(2):405-16. doi: 10.1158/1078-0432.CCR-14-0464. Epub 2014 Nov 21.
9
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.整合素靶向溶瘤腺病毒 Ad5-D24-RGD 和 Ad5-RGD-D24-GMCSF 治疗晚期化疗耐药实体瘤患者。
Int J Cancer. 2012 Apr 15;130(8):1937-47. doi: 10.1002/ijc.26216. Epub 2011 Aug 8.
10
Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).一种新型溶瘤痘苗病毒的抗肿瘤疗效增强,该病毒编码针对 T 细胞免疫球蛋白和 ITIM 结构域(TIGIT)的完全单克隆抗体。
EBioMedicine. 2021 Feb;64:103240. doi: 10.1016/j.ebiom.2021.103240. Epub 2021 Feb 10.

引用本文的文献

1
Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer.携带GM-CSF和IL-7的溶瘤痘苗病毒增强胰腺癌的抗肿瘤免疫。
Biomedicines. 2025 Apr 5;13(4):882. doi: 10.3390/biomedicines13040882.
2
The golden Syrian hamster () as a model to decipher relevant pathogenic aspects of sheep-associated malignant catarrhal fever.金黄叙利亚仓鼠()作为一种模型,用于解读与绵羊相关的恶性卡他热的相关致病因素。
Vet Pathol. 2025 Feb 11;62(5):3009858251315115. doi: 10.1177/03009858251315115.
3
Cancer vaccines: an update on recent achievements and prospects for cancer therapy.
癌症疫苗:癌症治疗近期成果与前景的最新进展
Clin Exp Med. 2024 Dec 25;25(1):24. doi: 10.1007/s10238-024-01541-7.
4
Persistence of Infectious Canine Distemper Virus in Murine Xenotransplants of Canine Histiocytic Sarcoma Cells after Intratumoral Application.传染性犬瘟热病毒在犬源组织细胞瘤细胞异种移植瘤内的持续存在:瘤内应用后的研究
Int J Mol Sci. 2024 Jul 30;25(15):8297. doi: 10.3390/ijms25158297.
5
Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas.基因编辑和工程化干细胞平台为脑转移黑色素瘤的免疫治疗提供动力。
Sci Transl Med. 2023 May 31;15(698):eade8732. doi: 10.1126/scitranslmed.ade8732.
6
Recent advances in oncolytic virus therapy for hepatocellular carcinoma.肝细胞癌溶瘤病毒治疗的最新进展
Front Oncol. 2023 Apr 26;13:1172292. doi: 10.3389/fonc.2023.1172292. eCollection 2023.
7
Syrian hamster as an ideal animal model for evaluation of cancer immunotherapy.叙利亚仓鼠作为癌症免疫疗法评价的理想动物模型。
Front Immunol. 2023 Feb 27;14:1126969. doi: 10.3389/fimmu.2023.1126969. eCollection 2023.
8
An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer.溶瘤病毒疗法治疗胰腺癌的临床前和临床试验综述
Front Oncol. 2022 May 24;12:875188. doi: 10.3389/fonc.2022.875188. eCollection 2022.
9
Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors.用于增强实体瘤T细胞疗法的临床相关溶瘤病毒平台的比较
Mol Ther Oncolytics. 2020 Mar 19;17:47-60. doi: 10.1016/j.omto.2020.03.003. eCollection 2020 Jun 26.
10
Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity.多种免疫疗法可在无明显毒性的情况下有效治疗同源性脑肿瘤。
J Immunother Cancer. 2019 Jul 17;7(1):188. doi: 10.1186/s40425-019-0673-2.